Buehlmann



Calprotectin

Calprotectin is the best marker to discriminate between organic (IBD) and non-organic bowel disease (IBS). Calprotectin is a reliable indicator of inflammation in several pathologies. Patients suffering from IBS do not have increased faecal calprotectin values. Faecal calprotectin concentrations, as measured by the BÜHLMANN Calprotectin assays, are significantly elevated in patients with IBD and correlate well with endoscopic and histological assessment of disease activity.

test

IBD and IBS
Around 2 million people in Europe suffer from IBD. Morbus Crohn and Colitis ulcerosa are incurable serious chronic diseases of the intestinal tract. The symptoms are distressing, embarrassing and even debilitating. Once symptoms appear, they resemble those of other conditions of functional origin (IBS), which make it very difficult for doctors to correctly diagnose. IBS is often confused with ulcerative colitis and Crohn’s disease. The inflammation typical of these diseases is not present in IBS. It is assumed that IBS affects over 30 million people in Europe and results in over 2 million yearly visits to physicians. Twenty to 30 percent of all visits to gastro enterologists are due to symptoms of IBS. Calprotectin is a clear gatekeeper marker enabling the clinician to decide whether a patient should be referred for colonoscopy or to treat them for IBS symptoms.

IBD Disease Monitoring
The clinical course of most patients with IBD is marked by periods of remission with intermittent relapses characterized by increased intestinal inflammation. Numerous published studies, by Tibble et al. and others, have studied the levels of calprotectin in patients during the course of the disease. The results show that calprotectin is a good predictor of relapse in patients with IBD, thus giving clinicians an effective tool to adapt the patients treatment accordingly and to ease the relapse severity.

Product Information

Calprotectin

Method

ELISA/ Extraction

Time to results

2 h

Sample Type

50-150 µl faeces

Standard Range

10-600 µg/g / 30-1800 µg/g

Sensitivity

< 10 µg/g / < 30 µg/g

Order Code

EK-CAL 96 wells
CE

DOWNLOADS

Instruction
for use*                 

Clinical Information

Technical Information

Literature   

English

[PDF0.3MB] 

PSF001**

[PDF 0.9MB] [PDF 0.6MB] [PDF 0.3MB]

Deutsch

[PDF 0.9MB] [PDF 0.6MB] [PDF 0.3MB]

Francais

[PDF 0.9MB] [PDF 0.6MB] -

Italiano

[PDF 0.9MB] [PDF 0.6MB] -

* Multilingual document [EN, DE, FR, IT, ES]
** additional information for stool extraction using a Faecal Sample Preparation Kit

Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Your local distributor
Order
About us
Job opportunities

News

BUHLMANN as gold sponsor of the 5th Santorini Pharmacogenetics Conference

Functional Genomics Towards Personalized Health Care The 5th Santorini Conference will take place in Thira, Greece, on September 30th , October 1st and 2  more

Measuring of Mineralwaters and Softdrinks on Arena and Aquakem

The high expectations in speed, accuracy and precision have been achieved in an evaluation study on Arena 30 at Feldschlösschen (Carlsberg Group), Rheinfe  more

BÜHLMANN Calprotectin Test introduced in Belgium

The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation pro  more

Distribution of BioPorto’s NGAL ELISA

In January 2010 BÜHLMANN starts the distribution of the innovative diagnostic products of BioPorto in Switzerland , Austria and France .  more

Get our RSS - Feed